Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized L9NC in Metastatic Endometrial Cancer
NCT00249990Phase 2Completed
- Sponsor
- The University of New Mexico
- Start
- Apr 2003
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rubitecan in endometrial cancer (EC), sponsored by The University of New Mexico. Started Apr 2003; status: completed.
02
Drugs
rubitecan
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00249990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249990.